Information Provided By:
Fly News Breaks for July 30, 2015
PODD
Jul 30, 2015 | 11:02 EDT
As previously reported, Feltl upgraded Insulet to Hold from Sell. Analyst Ben Haynor believes the surprising preliminary Q2 release and postponement of full results is odd behavior and may indicate an "acquisition may be afoot." Haynor increased his price target on Insulet to $35 based upon the multiple St. Jude (STJ) is paying to acquire Thoratec (THOR).
News For PODD From the Last 2 Days
There are no results for your query PODD